# Commission decision of 27 March 2007 on the allocation of quantities of controlled substances allowed for essential uses in the Community in 2007 under Regulation (EC) No 2037/2000 of the European Parliament and of the Council (notified under document number C(2007) 1285) (Only the Danish, Dutch, English, Estonian, French, German, Italian, Slovenian and Spanish texts are authentic) (Text with EEA relevance) (2007/211/EC), Annex III: Essential laboratory uses

Extent: E+W+S+N.I.

Quota of controlled substances of Group I and II that may be used for laboratory and analytical uses, are allocated to:
Acros Organics bvba (BE)
Bie & Berntsen A-S (DK)
Carlo Erba Reactifs-SDS (FR)
Harp International (UK)
Honeywell Specialty Chemicals (DE)
Ineos Fluor (UK)
LGC Promochem (DE)
Mallinckrodt Baker (NL)
Merck KGaA (DE)
Mikro+Polo d.o.o. (SI)
Panreac Química S.A. (ES)
Sanolabor d.d. (SI)
Sigma Aldrich Chimie (FR)
Sigma Aldrich Logistik (DE)
Tazzetti Fluids (IT)
VWR I.S.A.S. (FR)

---
Source: https://www.legislation.gov.uk/eudn/2007/211/annex/III (the official version)
Page: https://openlegislation.uk/eu-decision-2007-211/annex-III
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.